Onychomycosis Treatment Market is expected to progress at a 7% CAGR through 2031.

The prevalence of onychomycosis has been increasing over the past few years due to unhealthy lifestyle and negligence of nail care. Future Market Insights (FMI) presents a positive outlook for the onychomycosis treatment market, forecasting it to exhibit 6.1% Y-o-Y growth in 2021.

According to a recent study published by National Center for Biotechnology Information (NCBI) in May 2020, the overall prevalence of onychomycosis was approximately 5.5% in the general population.

Toenail onychomycosis are more common and requires longer duration of treatment, which can also extend to a year. Sometimes complete cure, defined as clinical cure, is unattainable, which may lead to indefinite treatment duration and consequently drive the onychomycosis treatment market. The risk of onychomycosis is 1.9 to 2.8 times higher in people with diabetes, compared with the general population. This is leading to rising revenue accumulation of drug manufacturers targeting the onychomycosis treatment market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1279

The increasing risk factors such as nail injury or nail surgery, diabetes, weakened immune system, blood circulation disorders, athlete's foot or ringworm, and others are driving the onychomycosis treatment market. The growing risk of occupational hazards such as agriculture, waste disposal, and others is also propelling the growth of the onychomycosis treatment market.

Diabetes and related conditions contributing to poor peripheral circulation are the major drivers of the market. Onychomycosis may represent an important forecast for the development of diabetic foot syndrome and foot ulcers. Patients who are immunosuppressed, such as those undergoing cancer therapy and those with HIV infection also are predisposed to fungal nail infection.

Coronavirus pandemic has changed the public medical care needs and spending however this is viewed as transient effect on the onychomycosis treatment market. The increasing COVID-19 patient pool attracted spotlight to the treatment of these patients on emergency basis, consequently reducing the patient visits to the medical clinics for onychomycosis treatment.

Decreasing visits demonstrate lesser treatment reception that resulted in temporary contraction of sales. Nonetheless, demand is likely to recover in the coming years with drugs emerging as more preferred type of treatment. The drugs segment is expected to account for nearly 75% of revenue generated in the market.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/onychomycosis-treatment-market

Key Takeaways from Onychomycosis Treatment Market Study

High spending power supports growth in the U.S., sealing its dominance in North America. The U.S. is expected to account for over 84% of sales registered in the region
The demand from the U.K. will continue rising, enabling year-on-year growth at above 7%
Germany and France too will continue exhibiting high demand
Within East Asia, Japan holds dominance, yet demand from China is likely to rise at a higher pace

“Market players are likely to focus on merger and acquisition to expand their footprint worldwide. They are also expected to focus on capitalizing on opportunities across emerging economies to gain competitive advantage,” said an FMI analyst.

Geriatric Population More Susceptible Onychomycosis

According to the World Health Organization (WHO), age is the key risk factor for the development of onychomycosis and the risk for onychomycosis increases with age, particularly for persons aged >50 years. Approximately, about 80-85% of onychomycosis occurs in patients aged greater than 50 years, globally. The rise in elderly population will therefore present lucrative growth opportunities to onychomycosis treatment market.

Who is Winning?

Key players in the onychomycosis treatment market are keenly focusing on strategic activities such as acquisitions, collaborations and mergers in order to create a strong position.

For Instance, In September 2018, Almirall S.A. acquired of portfolio of five products comprising of Allergan’s Medical dermatology unit in the U.S. to further enhance the company’s dermatology portfolio.

In 2017, Ziarco Group ltd. was acquired by Novartis acquired. Ziarco Group ltd. a privately held company in the U.K. The company focuses on the development of novel treatments in the field of dermatology.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1279

Key Players :

Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Medimetriks Pharmaceuticals, Inc.
Galderma
Johnson & Johnson
Novartis AG
Moberg Pharma AB
Cardinal Health, Inc.
Pfizer Inc.
Almirall, S.A.
Bayer AG
Viatris Inc.
GlaxoSmithKline plc
Cipla Ltd.
Dr. Reddy’s Laboratories Ltd

Onychomycosis Treatment Market by Category

Treatment Type

Drugs
Oral
Rx
OTC
Topical
Rx
OTC
Lasers
C02 Ablative Lasers
Nd:YAG Lasers
Dual-wavelength near-infrared Lasers
Photodynamic Therapy

Disease Indication

Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candidal Onychomycosis
Total Dystrophic Onychomycosis

Age Group

0-18 Years
18-39 Years
40-64 Years
65 Years & Above

Gender

Male
Female

Distribution Channel

Institutional Sales
Hospitals
Dermatology Clinics
Retail Sales
Retail Pharmacies
Drug Stores
Mail Order Pharmacies & Online Sales

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1279

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.